Torsemide: Potent Loop Diuretic for Effective Fluid Management
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.43 | $38.70 (0%) | 🛒 Add to cart |
| 120 | $0.39 | $51.60 $46.44 (10%) | 🛒 Add to cart |
| 180 | $0.33 | $77.40 $60.20 (22%) | 🛒 Add to cart |
| 270 | $0.31 | $116.10 $83.42 (28%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $154.80 $104.06 (33%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.76 | $45.58 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $68.37 $61.92 (9%) | 🛒 Add to cart |
| 120 | $0.65 | $91.16 $78.26 (14%) | 🛒 Add to cart |
| 180 | $0.62 | $136.74 $110.94 (19%) | 🛒 Add to cart |
| 270 | $0.59 | $205.11 $159.10 (22%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $273.48 $208.12 (24%) | 🛒 Add to cart |
Synonyms | |||
Torsemide is a high-ceiling loop diuretic indicated for the treatment of edema associated with congestive heart failure, renal disease, and hepatic cirrhosis. It acts on the ascending limb of the loop of Henle to inhibit the sodium-potassium-chloride cotransporter, promoting significant aquaresis and natriuresis. Its predictable pharmacokinetic profile, including high bioavailability and a longer half-life compared to furosemide, makes it a cornerstone therapy in managing fluid overload in various clinical settings. This agent is essential for clinicians seeking a reliable and potent diuretic option for patients requiring aggressive fluid removal.
Features
- Active Ingredient: Torsemide
- Pharmacologic Class: Loop diuretic
- Available Strengths: 5 mg, 10 mg, 20 mg, 100 mg tablets
- Bioavailability: Approximately 80%
- Onset of Action: Within 1 hour (oral)
- Peak Effect: 1-2 hours (oral)
- Duration of Action: 6-8 hours
- Elimination Half-Life: 3.5 hours
- Metabolism: Primarily hepatic via CYP2C9
- Excretion: Urine (80%) and feces (20%)
Benefits
- Effective Fluid Removal: Promotes rapid and significant diuresis, reducing edema and pulmonary congestion in heart failure patients.
- Improved Symptom Management: Alleviates dyspnea and peripheral edema, enhancing patient comfort and functional capacity.
- Predictable Pharmacokinetics: High oral bioavailability and consistent absorption reduce interpatient variability in response.
- Convenient Dosing: Once-daily dosing is effective for most patients, supporting adherence.
- Potential Cardioprotective Effects: Some evidence suggests beneficial effects on cardiac remodeling and reduced hospitalization rates in chronic heart failure.
- Flexible Use: Suitable for both chronic maintenance therapy and acute decompensation scenarios.
Common use
Torsemide is primarily prescribed for the management of edema due to congestive heart failure, chronic kidney disease, and hepatic cirrhosis. It is also used in the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents. In clinical practice, it is often selected for patients who exhibit resistance or suboptimal response to other loop diuretics like furosemide, owing to its more reliable absorption and potent effect.
Dosage and direction
Dosage must be individualized based on patient response, renal function, and clinical condition. For edema in congestive heart failure or chronic renal failure, the usual initial dose is 10-20 mg once daily, which may be increased to 200 mg daily as needed. For hepatic cirrhosis, start with 5-10 mg once daily, administered concomitantly with an aldosterone antagonist or potassium-sparing diuretic. For hypertension, the usual starting dose is 5 mg once daily, which may be increased to 10 mg after 4-6 weeks if necessary. Administer in the morning to avoid nocturia. Monitor electrolytes and renal function periodically.
Precautions
Monitor serum electrolytes (particularly potassium, sodium, magnesium, and calcium), blood urea nitrogen, creatinine, and uric acid regularly, especially during initial therapy or after dose adjustments. Use with caution in patients with preexisting electrolyte abnormalities, hypotension, or dehydration. Risk of ototoxicity is increased with rapid intravenous administration, concurrent use of other ototoxic drugs, or in patients with renal impairment. Photosensitivity reactions may occur; advise sun protection. In patients with diabetes, torsemide may decrease glucose tolerance. Use cautiously in patients with sulfonamide allergy, as cross-reactivity may occur.
Contraindications
Torsemide is contraindicated in patients with known hypersensitivity to torsemide or any sulfonylurea-derived agents. It is also contraindicated in anuria and in patients in hepatic coma or states of severe electrolyte depletion until the condition is improved or corrected. Not recommended during breastfeeding due to potential secretion in human milk.
Possible side effect
Common adverse reactions include:
- Headache
- Dizziness
- Asthenia
- Electrolyte depletion (hypokalemia, hyponatremia, hypomagnesemia, hypocalcemia)
- Hyperglycemia
- Hyperuricemia
- Increased blood urea nitrogen
- Orthostatic hypotension
- Photosensitivity
Less common but serious side effects may include:
- Ototoxicity (tinnitus, hearing loss)
- Severe dehydration
- Thrombocytopenia
- Stevens-Johnson syndrome
- Pancreatitis
- Allergic reactions (rash, anaphylaxis)
Drug interaction
Torsemide may interact with:
- Other antihypertensives: Enhanced hypotensive effect.
- Digoxin: Hypokalemia may increase risk of digoxin toxicity.
- Lithium: Reduced renal clearance of lithium; increased risk of toxicity.
- NSAIDs: May reduce diuretic and antihypertensive efficacy.
- Aminoglycosides, cisplatin: Increased risk of ototoxicity and nephrotoxicity.
- Probenecid: Reduces diuretic effect.
- Corticosteroids, amphotericin B: Enhanced hypokalemia.
- Warfarin: Potential alteration in anticoagulant effect (monitor INR).
- Chloral hydrate: Reported cases of sweating, flushing, and instability.
- Salicylates: Increased risk of salicylate toxicity at higher doses.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the usual dosing schedule. Do not double the dose to make up for a missed one.
Overdose
Symptoms of overdose include profound water loss, electrolyte depletion (especially hypokalemia), dehydration, reduction in blood volume, circulatory collapse, and possibly vascular thrombosis and embolism. Treatment is supportive and symptomatic, focusing on fluid and electrolyte replacement. Hemodialysis does not significantly remove torsemide.
Storage
Store at controlled room temperature, 20-25°C (68-77°F). Protect from light and moisture. Keep in the original container, tightly closed. Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Do not disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
“Torsemide has been a game-changer in our heart failure clinic. Patients who were refractory to furosemide have shown significant improvement in edema and functional status. The once-daily dosing is a major advantage for adherence.” – Cardiologist, MD
“In hepatic patients, torsemide, combined with spironolactone, provides predictable and manageable diuresis without the sharp peaks seen with other agents. Electrolyte monitoring is key, but the profile is favorable.” – Hepatologist, MD
“While effective, we remain vigilant for hypokalemia, especially in elderly patients on multiple medications. The consistent absorption is a clinical plus compared to furosemide.” – Nephrologist, MD